{
    "2021-07-06": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Psychedelic Startups Investors are Flocking To",
                "features": {
                    "keywords": [
                        "psychedelic",
                        "startups",
                        "investors"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Eli Lilly, Boehringer Ingelheim Touts Heart Failure Win For Jardiance",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Boehringer Ingelheim",
                        "Jardiance",
                        "heart failure"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Why investors are leaving work-from-home stocks behind",
                "features": {
                    "keywords": [
                        "investors",
                        "work-from-home",
                        "stocks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Breakthrough results for JardianceÂ® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction",
                "features": {
                    "keywords": [
                        "Jardiance",
                        "empagliflozin",
                        "EMPEROR-Preserved",
                        "heart failure",
                        "trial success"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}